<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>4
<FILENAME>file003.txt
<DESCRIPTION>LETTER
<TEXT>
<PAGE>

                             KANDERS & COMPANY, INC.
                               TWO SOUNDVIEW DRIVE
                          GREENWICH, CONNECTICUT 06830


                                 March 20, 2002


Mr. Stephen P. Jeffrey
Chairman, President and Chief Executive Officer;
and the Secretary and Board of Directors
Clarus Corporation
3970 Johns Creek Court
Suwanee, Georgia 30024

Dear Sirs:

         We are writing to you as a significant shareholder (owner of 724,000
shares of the Company's stock held in street name) to express our concerns
regarding the decline in the overall performance of Clarus Corporation (the
"Company") and the negative performance of the Company's common stock.
Specifically:

         o    The Company's revenues during the first three (3) quarters of 2001
              decreased 34.7%, 40.6% and 77.7% respectively, from a year ago.

         o    The Company's common stock is currently trading near the bottom of
              its 52 week range, less than three (3%) percent of its peak price
              of $136.00 per share two years ago and at approximately 50% of
              management's lowered forecast of the Company's cash low watermark
              for fiscal year 2002.

         o    The high turnover of senior management, including the loss of the
              Company's Executive Vice President and Chief Strategy Officer in
              the face of an extremely challenging sales environment.

         o    Management's withdrawal of its forecast of being cash flow
              positive in fiscal year 2002.

         o    Current cash burn rate of approximately $4 million a quarter.

         o    No sign of improved traction of the Company's software technology.

         Unfortunately, the Company's efforts to address these concerns have not
been successful.

<PAGE>

Mr. Stephen P. Jeffrey
Clarus Corporation
March 20, 2002
Page 2


         We are dismayed by the Company's lack of success in responding to these
issues. To date, the Company's business strategies have failed to maximize the
Company's assets for the benefit of stockholders resulting in a stagnant stock
price. As you know a stagnant share valuation restricts the Company's ability to
motivate and build wealth for employees, thereby reducing its ability to attract
high caliber talent, and to pursue accretive acquisitions.

         It is therefore critical that the Company consider various strategic
alternatives to its current strategy of "business as usual" by promptly
implementing certain specific actions to enhance shareholder value, including:

              o    My appointment or election to the Board of Directors,
                   together with two of my colleagues, persons with substantial
                   economic and financial expertise and business acumen to
                   present the Company with, and who are capable of
                   implementing, strategic alternatives.

              o    Retention of a recognized investment banking firm to evaluate
                   the potential sale of the Company's software technology and
                   maximize shareholder value through redeployment of the
                   Company's capital, including cash and NOL.

              o    Drastically reduce the Company's burn rate pending Board
                   review of the strategic alternatives presented.

              My two colleagues and I meet all the criteria for serving on the
Board of Directors required by applicable law and the Company's bylaws and are
amenable to serving as directors of the Company if nominated in connection with
the Company's 2002 annual meeting of shareholders.

              By way of background, I have served as the Chairman of the Board
of Armor Holdings, Inc. (NYSE) since January 1996, and Vice Chairman of the
Board of Benson Eyecare Corporation (NYSE) from October 1992 to May 1996. I have
a proven track record of significantly enhancing shareholder value, not only in
Armor Holdings and Benson Eyecare, but with other small and midsize public
companies, utilizing my substantial experience in mergers and acquisition
strategies and investment activities. As Chairman of Armor Holdings my
contributions to strategic planning, growth through acquisition, and investor
relations have contributed to Armor's market capitalization increasing from $6
million to $800 million during the six years in which I have been involved.
Similarly, during my tenure at Benson Eyecare, its financial performance and
market capitalization increased in similar fashion. You can be assured that I
will bring the same effort, expertise and recognition in the investment
community to the benefit of Clarus.

<PAGE>

Mr. Stephen P. Jeffrey
Clarus Corporation
March 20, 2002
Page 3


              My two colleagues, Burtt R. Ehrlich and Nicholas Sokolow, who I am
also proposing for nomination as directors of the Company, have also played
active and strategic roles in Armor Holding's growth in their capacity as
directors.

              For your review, listed below our biographical information.

              Warren B. Kanders: I am a 44 years old, an independent investor
and financial consultant, and I have served as the Chairman of the Board of
Armor Holdings, Inc. (NYSE) since January 1996. I also serve as a director on
the Board of several investment companies including Avocet European Technology
Fund Limited, a privately held investment company focused on public technology
investments in the EU market, and from October 1992 to May 1996, I served as
Vice Chairman of the Board of Benson Eyecare Corporation (NYSE). My address is
c/o Kanders & Company, Inc., Two Soundview Drive, Greenwich, Connecticut 06830.

              Burtt R. Ehrlich: Mr. Ehrlich, also an independent investor, is 62
years old and has served as a director of Armor Holdings, Inc. since January
1996. He has also served as Chairman of the Board of Langer, Inc. (NASDAQ) since
February 2001, and served as Chairman and Chief Operating Officer of Ehrlich
Bober Financial Corp. (the predecessor of Benson Eyecare Corporation) from
December 1986 until October 1992 and as a director of Benson Eyecare Corporation
from October 1992 until November 1995. Mr. Ehrlich's address is Two Soundview
Drive, 3rd Floor, Greenwich, CT 06830.

              Nicholas Sokolow: Mr. Sokolow, a practicing attorney, is 51 years
old and has served as a director of Armor Holdings, Inc. since January 1996.
Since 1994 he has been a partner in the law firm of Sokolow, Dunaud, Mercadier &
Carreras, and from June 1973 until October 1994, Mr. Sokolow was an associate
and partner in the law firm of Coudert Brothers. Mr. Sokolow's address is c/o
Sokolow, Dunaud, Mercadier & Carreras, 55 Avenue Kleber, Paris 75016 France.

<PAGE>

Mr. Stephen P. Jeffrey
Clarus Corporation
March 20, 2002
Page 4


              This letter is submitted by me and on behalf of Messrs. Ehrlich
and Sokolow, each as independent investors, and not as representatives of any
other person. I am available to meet in person or by telephone with any director
that wishes to discuss our comments or recommendations. Be assured that our
interest in Clarus, as investors intent on improving its value to stockholders,
is long term and we believe that other stockholders may share our view. I
request that a copy of this letter be given to all members of the Company's
Board of Directors and look forward to receiving a prompt response.

                                           Very truly yours,

                                           KANDERS & COMPANY, INC.


                                           By: /s/ Warren B. Kanders
                                              --------------------------------
                                               Warren B. Kanders, President


</TEXT>
</DOCUMENT>
